9N6

N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamide

Created:	2023-07-14
Last modified:	2025-11-26

Find Related PDB Entry
1 entries where 9N6 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	93
Chiral Atom Count	1
Bond Count	96
Aromatic Bond Count	12

2D diagram of 9N6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamide
Systematic Name (OpenEye OEToolkits)	~{N}-ethyl-5-fluoranyl-2-[[5-[2-[(3~{R})-6-[2-methoxyethyl(methyl)amino]-2-methyl-hexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-~{N}-propan-2-yl-benzamide
Formula	C₃₂ H₅₀ F N₇ O₃
Molecular Weight	599.783
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CC(C)N(CC)C(=O)c1cc(F)ccc1Oc1nncnc1N1CCC2(CN(C2)C(CCCN(C)CCOC)C(C)C)C1
SMILES	CACTVS	3.385	CCN(C(C)C)C(=O)c1cc(F)ccc1Oc2nncnc2N3CCC4(CN(C4)[CH](CCCN(C)CCOC)C(C)C)C3
SMILES	OpenEye OEToolkits	2.0.7	CCN(C(C)C)C(=O)c1cc(ccc1Oc2c(ncnn2)N3CCC4(C3)CN(C4)C(CCCN(C)CCOC)C(C)C)F
Canonical SMILES	CACTVS	3.385	CCN(C(C)C)C(=O)c1cc(F)ccc1Oc2nncnc2N3CCC4(CN(C4)[C@H](CCCN(C)CCOC)C(C)C)C3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCN(C(C)C)C(=O)c1cc(ccc1Oc2c(ncnn2)N3CCC4(C3)CN(C4)[C@H](CCCN(C)CCOC)C(C)C)F
InChI	InChI	1.06	InChI=1S/C32H50FN7O3/c1-8-40(24(4)5)31(41)26-18-25(33)11-12-28(26)43-30-29(34-22-35-36-30)38-15-13-32(19-38)20-39(21-32)27(23(2)3)10-9-14-37(6)16-17-42-7/h11-12,18,22-24,27H,8-10,13-17,19-21H2,1-7H3/t27-/m1/s1
InChIKey	InChI	1.06	PDUGAXSIWNMIBQ-HHHXNRCGSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB19328
Name	Bleximenib
Groups	investigational
Description	Bleximenib is under investigation in clinical trials NCT04811560 (A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia) and NCT05453903 (A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies)
Synonyms	Bleximenib Benzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)- N-ethyl-5-fluoro-2-{[5-(2-{(3R)-6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl}-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl]oxy}-N-(propan-2-yl)benzamide JNJ-75276617
CAS number	2654081-35-1

Related Resource References

Resource Name	Reference
PubChem	156498110
ChEMBL	CHEMBL5314509

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.